Joerg Kaufmann

Title: Joerg Kaufmann: Innovator in Signal Modulation Techniques

Introduction

Joerg Kaufmann is a notable inventor based in Iffeldorf, Germany. He has made significant contributions to the field of interaction assays, particularly in methods for modulating signal intensity. His innovative approaches have the potential to enhance the accuracy and efficiency of various analytical processes.

Latest Patents

Kaufmann holds a patent for "Methods for modulating signal intensity in interaction assays." This patent includes a method for determining an analyte in a sample by contacting it with an interaction modulator. The interaction modulators mentioned in the patent include Poly-(4-styrenesulfonic acid-co-maleic acid) (PSSM), aminodextran, carboxymethyldextran, Poly-(2-acrylamido-2-methyl-1-propanesulfonic acid (PAMPS), triethylamine, triethanolamine, taurine, and dodecylsulfate. The method is designed to enhance the interaction assay at low analyte concentrations while acting as a retarder at high concentrations. Additionally, the patent describes a kit that includes a detection agent specifically for the analyte and at least one interaction modulator, along with devices related to these methods and kits.

Career Highlights

Kaufmann is currently employed at Roche Diagnostics Operations, Inc., where he continues to develop innovative solutions in the field of diagnostics. His work focuses on improving the methodologies used in interaction assays, which are crucial for various applications in medical and scientific research.

Collaborations

Throughout his career, Kaufmann has collaborated with esteemed colleagues such as Georg Kurz and Eloisa Lopez-Calle. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Joerg Kaufmann's contributions to the field of signal modulation in interaction assays highlight his innovative spirit and dedication to advancing scientific research. His patent and ongoing work at Roche Diagnostics Operations, Inc. demonstrate his commitment to improving diagnostic methodologies.